Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Why Do We Adjust Index Divisor covers the core reasons behind adjustments, including corporate actions and market events, and how they affect benchmarks.
20,620 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
In a dramatic Q1, a bold Bitcoin-focused strategy posts a $12.5 billion loss. This article explains what happened, wh...
A Layer-3 token listed on South Korea's Upbit surged in minutes, triggering a rapid rally described by traders as a v...
A new mobile AI for health claims to run entirely on your device, delivering medical insights faster and with far les...
In a crowded AI market, a stock nobody watching that quietly compounds growth could deliver outsized returns. This gu...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
Arm Holdings’ stock has jumped sharply this year on AI data center demand, yet a valuation gap and monetization hurdl...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
Oxbridge Re kicks off 2026 with a Q1 that mixes solid underwriting with measured investment moves. This deep dive exp...